Below are some video excerpts from our HealthTree University curriculum to help you learn more about these important areas of your disease. By creating a HealthTree account, in HealthTree University you can:
Save and keep track of your progress in the courses
Get points for answering quiz questions
Earn prizes [COMING SOON]
And get access to all the other incredible features of HealthTree!
6.11 - How is maintenance therapy adapted to myeloma risk?
6.12 - How do I know if I am responding to treatment or in remission?
6.13 - What tests are used to assess response to treatment?
6.14 - When should a patient consider changing a therapy?
6.15 - What are the different catheters and ports?
We’d like to thank our faculty who donated their time in creating these videos, including:
Sagar Lonial, MD, FACP of Winship Cancer Institute of Emory University
Peter Voorhees, MD of Levine Cancer Institute
Aaron Rosenberg, MD, MS of UC Davis Comprehensive Cancer Center
Adam Cohen, MD of Penn Medicine - Abramson Cancer Center
Jeffrey Zonder, MD of Karmanos Cancer Institute
Angela Dispenzieri, MD of Mayo Clinic, Rochester
Rafael Fonseca, MD of Mayo Clinic, Scottsdale
Saad Usmani, MD, FACP of Levine Cancer Institute
Natalie Callander, MD of University of Wisconsin
Mike Thompson, MD, PhD, FASCO of Advocate Aurora Health
Omar Nadeem, MD of Dana-Farber Cancer Institute
Ajai Chari, MD of Icahn School of Medicine at Mount Sinai
Jesus Berdeja, MD of Sarah Cannon Research Institute
We have over 200 HealthTree University videos online at university.healthtree.org ! Learn the basics (and the not-so-basics) of myeloma from some of the top myeloma doctors in the world!
Other HealthTree University Classes:
Myeloma Basics Part 1
Myeloma Basics Part 2
Myeloma Basics Part 3
Building Your HealthCare Team
Becoming an Empowered Patient
Starting Myeloma Treatment
Autologous Stem Cell Transplant (ASCT)
Relapsed and Refractory MM Treatment
Myeloma Bone Disease
Testing, Monitoring MM Markers
[BETA] Multiple Myeloma Genetics and Precision Medicine
Classes of Myeloma Drugs
[BETA] COVID-19 and Multiple Myeloma